The receptor for advanced glycation end products (RAGE) is a non-specific multi-ligand
pattern recognition receptor capable of binding to a range of structurally diverse ligands …

Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality.
Consequences vary from mild cognitive impairment to death and, no matter the severity of …

Advanced glycation end products (AGEs) are formed as a result of non-enzymatic reaction
between the free reducing sugars and proteins, lipids, or nucleic acids. AGEs are …

Background Understanding the intricate signaling network involved in triple-negative breast
cancer (TNBC) represents a challenge for develo** novel therapeutic approaches. Here …

The involvement of cardiovascular disease in cancer onset and development represents a
contemporary interest in basic science. It has been recognized, from the most recent …

Glycation is a nonenzymatically catalyzed spontaneous reaction that eventually leads to the
formation of advanced glycation end-products (AGEs), which can bind to the receptor for …

From attributing mutations to cancers with the advent of cutting-edge genetic technology in
recent decades, to re-searching the age-old theory of intrinsic metabolic shift of cancers …

Receptor for advanced glycation end products (RAGE) is an immunoglobulin-like receptor
present on cell surface. RAGE binds to an array of structurally diverse ligands, acts as a …

Years of investigation have shed light on a theory in which breast tumor epithelial cells are
under the effect of the stromal microenvironment. This review aims to discuss recent findings …

Increased production of advanced glycation end products (AGEs) among reducing sugars
(glucose, fructose, galactose, or ribose) and amino acids/proteins via non-enzymatic …